Pelthos Therapeutics Inc. to acquire Castle Creek Biosciences, Inc.
Pelthos Therapeutics Inc. signed an Agreement and Plan of Merger on October 30, 2026 to acquire Castle Creek Biosciences, Inc., according to Pelthos's Form 8-K of that d…
- Buyer
- Pelthos Therapeutics Inc.
- Target
- Castle Creek Biosciences, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
